AU8580598A - Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders - Google Patents

Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders

Info

Publication number
AU8580598A
AU8580598A AU85805/98A AU8580598A AU8580598A AU 8580598 A AU8580598 A AU 8580598A AU 85805/98 A AU85805/98 A AU 85805/98A AU 8580598 A AU8580598 A AU 8580598A AU 8580598 A AU8580598 A AU 8580598A
Authority
AU
Australia
Prior art keywords
sorders
neuropsychiatric
diagnosis
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85805/98A
Inventor
Hong Chen
Nelson B. Freimer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Millennium Pharmaceuticals Inc
Original Assignee
University of California
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Millennium Pharmaceuticals Inc filed Critical University of California
Publication of AU8580598A publication Critical patent/AU8580598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU85805/98A 1997-07-22 1998-07-22 Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders Abandoned AU8580598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89808297A 1997-07-22 1997-07-22
US08898082 1997-07-22
PCT/US1998/015183 WO1999004825A1 (en) 1997-07-22 1998-07-22 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

Publications (1)

Publication Number Publication Date
AU8580598A true AU8580598A (en) 1999-02-16

Family

ID=25408913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85805/98A Abandoned AU8580598A (en) 1997-07-22 1998-07-22 Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders

Country Status (3)

Country Link
AU (1) AU8580598A (en)
CA (1) CA2298474A1 (en)
WO (1) WO1999004825A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897022B2 (en) 1996-03-29 2005-05-24 University Of Miami Susceptability and resistance genes for bipolar affective disorder
AU2001233957A1 (en) * 2000-02-24 2001-09-03 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression
US20020034783A1 (en) * 2000-04-18 2002-03-21 Rachel Meyers 39228, a novel human alcohol dehydrogenase and uses therefor
UA79927C2 (en) * 2000-12-05 2007-08-10 Serono Genetics Inst Sa Polynucleotide, coding a polypeptide of potential-depending portal ionic human channel (canion), polypeptyde, antibody, method for identification of candidate modulator of canion-polypeptyde, method for treatment of bipolar disorder or schizophrenia and use of an antibody for production of drugs for treatment of schizophrenia or bipolar disorder
DE102006018392A1 (en) * 2006-04-20 2007-10-25 Neuroprofile Gmbh Therapeutic targets for the development of novel drugs for degenerative diseases

Also Published As

Publication number Publication date
WO1999004825A1 (en) 1999-02-04
WO1999004825A8 (en) 1999-03-25
WO1999004825A9 (en) 1999-04-29
CA2298474A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
AU2212299A (en) Compositions and methods for the treatment of tumor
GB0015235D0 (en) Compositions for the treatment of skin and anorectal conditions
AU1136297A (en) Methods and compositions for diagnosis of hyperhomocysteinemia
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU1774097A (en) Pharmaceutical compositions for the treatment of rhinitis
IL136110A0 (en) Methods and compositions for the treatment of psoriasis
AU2821295A (en) Compositions and methods for the treatment of tumors
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9903852A3 (en) Process for the preparation of contrast agents
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU3966895A (en) Methods and compositions for the diagnosis of flea allergies
AU5699396A (en) Compositions for the treatment of skin conditions
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase